Occudo Quantitative Strategies LP Pmv Pharmaceuticals, Inc. Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.77 - $9.16 $48,987 - $94,073	10,270 Added 55.4%	28,808 $137,000
Q4 2022 Feb 14, 2023	SELL	$8.17 - $12.95 $102,345 - $162,224	-12,527 Reduced 40.33%	18,538 $161,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $225,138 - $339,287	19,749 Added 174.52%	31,065 $370,000
Q2 2022 Aug 15, 2022	BUY	$9.23 - $22.43 $104,446 - $253,817	11,316 New	11,316 $161,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.